Host Cell Death Responses to Non-typhoidal Salmonella Infection

subsp. serovar Typhimurium ( . Typhimurium) is a Gram-negative bacterium with a broad host range that causes non-typhoidal salmonellosis in humans. . Typhimurium infects epithelial cells and macrophages in the small intestine where it replicates in a specialized intracellular niche called the -conta...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 10; p. 1758
Main Authors: Wemyss, Madeleine A, Pearson, Jaclyn S
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 26-07-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:subsp. serovar Typhimurium ( . Typhimurium) is a Gram-negative bacterium with a broad host range that causes non-typhoidal salmonellosis in humans. . Typhimurium infects epithelial cells and macrophages in the small intestine where it replicates in a specialized intracellular niche called the -containing vacuole (SCV) and promotes inflammation of the mucosa to induce typically self-limiting gastroenteritis. Virulence and spread of the bacterium is determined in part by the host individual's ability to limit the infection through innate immune responses at the gastrointestinal mucosa, including programmed cell death. . Typhimurium however, has evolved a myriad of mechanisms to counteract or exploit host responses through the use of Type III Secretion Systems (T3SS), which allow the translocation of virulence (effector) proteins into the host cell for the benefit of optimal bacterial replication and dissemination. T3SS effectors have been found to interact with apoptotic, necroptotic, and pyroptotic cell death cascades, interfering with both efficient clearance of the bacteria and the recruitment of neutrophils or dendritic cells to the area of infection. The interplay of host inflammation, programmed cell death responses, and bacterial defenses in the context of non-typhoidal (NTS) infection is a continuing area of interest within the field, and as such has been reviewed here.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology
Present address: Madeleine A. Wemyss and Jaclyn S. Pearson, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia
Edited by: Barbara Bottazzi, Milan University, Italy
Reviewed by: Silvia Guglietta, Medical University of South Carolina, United States; Elsa Anes, University of Lisbon, Portugal
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2019.01758